Corrigendum to: Double PEGylation Significantly Improves Pharmacokinetic Properties of Irinotecan Containing Nanoparticles in a Zebrafish Model

Title:Corrigendum to: Double PEGylation Significantly Improves Pharmacokinetic Properties of Irinotecan Containing Nanoparticles in a Zebrafish Model

Volume: 11 Issue: 2

Author(s): Uday Saxena*, Marina Rajadurai*, Surendar Basaveni, Swapna Yellanki, Raghavender Medishetti, Aarti Sevilimedu and Pushkar Kulkarni

Affiliation:

• Vegrandis Therapeutics, Dr. Reddy’s Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad 500046,India

• Vegrandis Therapeutics, Dr. Reddy’s Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad 500046,India

Abstract: Due to an editorial oversight, we would like to apologize for an error that occurred in the print version of an article entitled “Double PEGylation Significantly Improves Pharmacokinetic Properties of Irinotecan Containing Nanoparticles in a Zebrafish Model, 2019, 9(2), 173-181 [1]. It was published as a case report; the article type has been changed to research article now.

Cite this article as:

Saxena Uday *, Rajadurai Marina *, Basaveni Surendar , Yellanki Swapna , Medishetti Raghavender , Sevilimedu Aarti and Kulkarni Pushkar , Corrigendum to: Double PEGylation Significantly Improves Pharmacokinetic Properties of Irinotecan Containing Nanoparticles in a Zebrafish Model, Current Nanomedicine 2021; 11 (2) . https://dx.doi.org/10.2174/246818731102210809145450